Short Summary

Occuity have developed a non-invasive device to screen for serious diseases (initially Diabetes & Alzheimer's but more planned) via a patient's eye. Team Incl. Ex Apple, 2 PhD's and Previous Exits. £500k already committed.


Investment Raised
Previous Rounds N/A
Stage MVP/Finished Product
Investor Role


  • Team hold PhD's in Bioengineering and Micro Optics as well as several exits
  • Non-invasive, handheld optical technology - screens for a range of diseases
  • Design director held main board report positions at Apple HQ (27 years)
  • Extensive granted patent portfolio with more in process
  • £500k already committed including follow-on from existing investors
Please note: Investing in early stage businesses involves risks, including illiquidity, lack of dividends, loss of investment and dilution, and it should be done only as part of a diversified portfolio. This platform is targeted solely at investors who are sufficiently sophisticated to understand these risks and make their own investment decisions. This information has not been approved as a financial promotion, and you must carry out your own due diligence.

Angel Investment Network (“AIN”) is not a Stock Exchange nor does it intend to get recognized as a stock exchange under Securities Contracts Regulation Act, 1956. AIN does not facilitate any online or offline buying, selling or dealing of securities, clearing or settlement of trades of securities. AIN is not a network or a platform for the secondary market trading.

Ask a question

Got a question about this project?

Sign up to view the full pitch

It's free to discover the next big thing

Already have an account?

Similar Projects

Global Pro
40% raised


location_on North East, United Kingdom

We are developing Nanorobots for early cancer detection, making it 10× cheaper and 100× faster than the current best detection method. Our nanorobots can capture cancer biomarkers in a patient's blood sample and light up to signal a positive result....

Rs. 9,30,00,000


Rs. 23,00,000

Min per Investor

Global Pro
25% raised

Miigen Seed Fund Raise

location_on Scotland, United Kingdom

Miigen is a social platform enhancing the wellbeing of the ageing population; EIS Approved; Secured 63k+ users in 125+ countries; Listed in top 50 Global StartUps (Feb 2019); Secured first US partner worth £80k+; £125k already committed.

Rs. 4,60,00,000


Rs. 9,30,000

Min per Investor

Global Pro
30% raised


location_on South East, United Kingdom

Occuity; Developed a patented, highly innovative, non-contact technology to detect & monitor chronic diseases; Targeting a $14bn market; Prototypes ready & successfully tested; 100+ yrs combined team experience; EIS eligibility; Already raised £300k...

Rs. 9,30,00,000


Rs. 4,60,000

Min per Investor

load one similar proposal